IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin

American Journal of Gastroenterology

Volumn 103, Issue 2, 2008, Pages 386-396

  Adams, Rachel J ^a   Heazlewood, Sharise P ^a   Gilshenan, Kristen S ^b   O'Brien, Mark ^c   McGuckin, Michael A ^a   Florin, Timothy H J ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MATER HOSPITAL   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MANNAN; MEMBRANE ANTIGEN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTEROIDES VULGATUS; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; ANTIGENS, BACTERIAL; CROHN DISEASE; FEMALE; FLAGELLIN; HUMANS; IMMUNOGLOBULIN G; INTESTINES; MALE; MANNANS;

EID: 39049142086     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01577.x     Document Type: Article

References (54)

1. Sendid B, Colombel J, Jacquinot P, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diag Lab Immunol 1996 3 : 219 26.
2. Israeli E, Grotto I, Gilburd B, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005 54 : 1232 6.
3. Main J, McKenzie H, Yeaman G, et al. Antibodies to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 1988 297 : 1105 6.
4. McKenzie H, Main J, Pennington C, et al. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut 1990 31 : 536 8.
5. Landers C, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease associated immune responses to auto- and microbial antigens. Gastroenterology 2002 123 : 689 99.
6. Young M, Davies MJ, Bailey D, et al. Characterization of oligosaccharides from an antigenic mannan of Saccharomyces cerevisiae. Glycoconj J 1988 15 : 815 22.
7. Mallant-Hent R, Mooij M, Blomberg BV, et al. Correlation between Saccharomyces cerevisiae DNA in intestinal mucosal samples and anti-Saccharomyces cerevisiae antibodies in serum of patients with IBD. World J Gastroenterol 2006 12 : 292 7.
8. Lodes M, Cong Y, Elson C, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004 113 : 1296 306.
9. Wang X, Heazlwood S, Krause D, et al. Molecular characterisation of the microbial species that colonise normal human ileal and colonic mucosa by using 16S rDNA sequence analysis. J Appl Microbiol 2003 95 : 508 21.
10. Dubinsky M, Lin Y, Dutridge D, et al. Serum immune responses predict rapid disease progression among children with Crohn's disease: Immune responses predict disease progression. Am J Gastroenterol 2006 101 : 360 7.
11. Helphingstine C, Hentges D, Campbell B, et al. Antibodies detectable by counterimmunoelectrophoresis against Bacteroides antigens in serum of patients with inflammatory bowel disease. J Clin Microbiol 1979 9 : 373 8.
12. Bamba T, Matsuda H, Endo M, et al. The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis. J Gastroeenterol 1995 30 (Supp 8 45 7.
13. Mow W, Vasiliauskas E, Lin Y, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004 26 : 414 24.
14. Kaila B, Orr K, Bernstein C. The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: Accurate in identifying cases of Crohn's disease and predicting inflammatory disease. Can J Gastroenterol 2005 19 : 717 21.
15. Vasiliauskas E, Kam L, Karp L, et al. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000 47 : 487 96.
16. Targan S, Landers C, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 2005 128 : 2020 8.
17. Jossens S, Colombel J, Landers C, et al. Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis. Gut 2006 55 : 1667 9.
18. Abreu M. Serologies in Crohn's disease: Can we change the gray zone to black and white? Gastroenterology 2006 131 : 664 6.
19. Dotan I, Fishman S, Dgani Y, et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 2006 131 : 366 78.
20. Papadakis K, Yang H, Ippoliti A, et al. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations. Inflamm Bowel Dis 2007 13 : 524 30.
21. Devlin S, Yang H, Ippoliti A, et al. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology 2007 132 : 576 86.
22. Ferrante M, Henckaerts L, Joossens M, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007 56:1394-403.
23. Macpherson A, Khoo UY, Forgacs I, et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996 38 : 365 75.
24. Murray RGE. Cell fractionation. In : Gerhardt P, ed. Methods for general and molecular bacteriology. Washington DC : American Society for microbiology, 1994 : 85 7.
25. Lindberg E, Magnusson K, Tysk C, et al. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut 1992 33 : 909 13.
26. Barnich N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli and Crohn's disease. Curr Opin Gastroenterol 2007 23 : 16 20.
27. Standaert-Vitse A, Jouault T, Vandewalle P, et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 2006 130 : 1764 75.
28. Bogaerde JVD, Kamm M, Knight S. Immune sensitization to food, yeast and bacteria in Crohn's disease. Aliment Pharmacol Ther 2001 15 : 1647 53.
29. Konrad A, Rutten C, Flogerzi B, et al. Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease. Inflamm Bowel Dis 2004 10 : 97 105.
30. Peeters M, Geypens B, Claus D, et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997 113 : 802 7.
31. Wyatt J, Vogelsang H, Hubi W, et al. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993 341 : 1437 41.
32. Schultsz C, Berg FVD, Kate F, et al. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 1999 117 : 1089 97.
33. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004 127 : 412 21.
34. Martin H, Campbell B, Hart C, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004 127 : 80 93.
35. Ryan P, Kelly R, Lee G, et al. Bacterial DNA within granulomas of patients with Crohn's disease - detection by laser capture microdissection and PCR. Am J Gastroenterol 2004 99 : 1539 43.
36. Macpherson A, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004 303 : 1662 5.
37. Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease. Clin Exp Immunol 1995 102 : 448 55.
38. Eckburg P, Bik E, Bernstein C, et al. Diversity of the human intestinal microbial flora. Science 2005 308 : 1635 8.
39. Vermeire S, Peeters M, Vlietinck R, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: A study in IBD families. Inflamm Bowel Dis 2001 7 : 8 15.
40. Harrer M, Reinisch W, Dejaco C, et al. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur J Gastroenterol Hepatol 2003 15 : 1281 5.
41. Sitaraman S, Klapproth J, Moore DA 3rd., et al. Elevated flagellin-specific immunoglobulins in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2005 288 : G403 6.
42. Sendid B, Quinton J, Charrier G, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 1998 93 : 1306 10.
43. Sutton C, Yang H, Li Z, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000 46 : 58 63.
44. Damoiseaux J, Bouten B, Linders A, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: High prevalence in patients with celiac disease. J Clin Immunol 2002 22 : 281 8.
45. Holstein A, Burmeister J, Plaschke A, et al. Autoantibody profiles in microscopic colitis. J Gastroenterol Hepatol 2006 21 : 1016 20.
46. Lawrance I, Murray K, Hall A, et al. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am J Gastroenterol 2004 99 : 2186 94.
47. Arnott I, Landers C, Nimmo E, et al. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 2004 99 : 2376 84.
48. Wolters F, Russel M, Sijbrandij J, et al. Disease outcome of IBD patients: General outline of a Europe-wide population-based 10-year clinical follow-up study. Scand J Gastroenterol Suppl 2006 46 54.
49. Schulzer M. Diagnostic tests: A statistical review. Muscle Nerve 1994 17 : 815 9.
50. Lasko T, Bhagwat J, Zou K, et al. The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 2005 38 : 404 15.
51. Linden A. Measuring diagnostic and predictive accuracy in disease management: An introduction to receiver operating characteristic (ROC) analysis. J Eval Clin Pract 2006 12 : 132 9.
52. Voss E, Wehkamp J, Wehkamp K, et al. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 2006 281 : 2005 11.
53. Wehkamp J, Salzman N, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 2005 102 : 18129 34.
54. Kramer M, Netea M, Jong DD, et al. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation. J Leukoc Biol 2006 79 : 860 6.